黑料吃瓜群网

The Minister for Health, Sussan Ley, has announced changes to the 聽Pharmaceutical Benefits Advisory Committee.
Dr Suzanne Hill, the Chair of the (PBAC), 聽will step down in March to聽take聽up a new role with the World Health Organization.聽The process to identify a new Chair has commenced.
Minister Ley said Dr Hill's leadership has seen the聽PBAC maintain聽its reputation as one of the premier technical and scientific advisory bodies in Australia.
鈥淒uring Dr Hill鈥檚 time as chair, the PBAC recommended many important new and innovative medicines for conditions including Hepatitis C, advanced melanoma, and cystic fibrosis, all of which have improved the quality of life of thousands of Australians,鈥� Ms Ley said.
鈥淭he role of the PBAC is a challenging one, navigating the difficult path of balancing the needs of patients, clinicians and industry with the complexities of making new and high cost medicines available for all Australians.
鈥淚mportantly, Dr Hill also strengthened the input of patients into the PBAC process, a goal which will continue to enrich the committee鈥檚 deliberations.鈥�
Ms Ley also announced four new appointments to the PBAC.
Professor Robyn Ward and Professor Andrew Roberts, long standing members of the PBAC with expertise in oncology and haematology, have been re-appointed for an additional four years. Dr Elizabeth Marles and Dr Thomas Snelling have also been appointed to the PBAC for four years.